Case Reports Indian Pediatrics 2003; 40:252-254 |
Pleural Effusion in Complicated Salmonella Paratyphi A Infection |
P. Mathur Renuka L. Simpson* From the Departments of Microbiology and Pediatrics*, All India Institute of Medical Sciences, New Delhi 110 029, India. Correspondence to: Dr. Purva Mathur, Senior Resident, Department of Microbiology, All India Institute of Medical Sciences, New Delhi 110 029, India.E-mail: [email protected] Manuscript received: August 30, 2001; Initial review completed: January 21, 2002; Revision accepted: November 6, 2002.
(20% neutrophils, 80% lymphocytes) and adequate number of platelets. Blood chemistry done after 48 hours of hospital-ization showed asparate aminotrans-ferase level of 176 IU/L, alanine amino-transferase 117 IU/L, alkaline phosphatase 544 IU/L, total bilirubin 0.6 mg/dL, direct bilirubin 0.3 mg/dL, total proteins 6.1 g/dL, albumin 3.6 g/dL, urea nitrogen 18 mg/dL, creatinine 0.5 mg/dL, sodium 137 mEq/L and potassium 4.1 mEq/L. The urine output at admission was 0.6 ml/kg/hour. Urinalysis showed traces to 1+ protein, no red cells, 2-3 epithelial cells and 10-15 white blood cells per HPF. No bacteria were seen. Microscopic examination of stool was normal. Viral markers for hepatitis A, B and C were negative. Ultrasonography of abdomen revealed a subpulmonic effusion on left side. Rest of abdomen including liver, gall bladder, spleen and kidney were within normal limits. Two samples each of blood, urine and stool were sent for culture. A small amount of pleural fluid, aspirated on two consecutie days, was also sent for culture and a serum sample sent for serological diagnosis of enteric fever. Cultures of urine were sterile and no pathogen was isolated from stool culture. However, both the samples of blood and pleural fluid grew S. paratyphi A, which was sensitive to ciprofloxacin and ceftriaxone but resistant to nalidixic acid, amoxicillin, cotrimoxazole and chloramphenicol by the standard NCCLS method. The MIC of ciprofloxacin was 0.19 µg/mL by E-test (AB Biodisk, Solne, Sweden). The titre of Somatic (0) and flagellar (H) antibodies for S. paratyphia A was >320. The child was treated with cefotaxime and cloxacillin initially. Once culture report was available the treatment was changed to ceftriaxone and cloxacillin was stopped. After one week of therapy, the pleural effusion resolved and the patient was afebrile. He was discharged after two weeks treatment with ceftriaxone. Discussion Enteric fever encompasses a disease with a range of severity, with typhoid fever being severe and paratyphoid fever a milder illness. Worldwide, it accounts for 16 million cases annually with an estimated 600,00 deaths(4). The disease is endemic in India with more than 3 lakh cases of enteric fever occurring each year(5). S. typhi accounts for the majority of infections. S. paratyphi A is less common but has shown a rising trend over the past five years whereas S. paratyphi B is rare(6). In a study done at a low income community of Delhi, the incidence of typhoid fever was 27.3/1000 person years in children under 5 years of age, 11.7 at 5-19 years and 1.1 between 19-40 years(7). In typhoid, involvement of liver is a consistent feature(3,8). The other common complications include relapse, perforation and hemorrhage from bowel ulcerations(3). However, such complications are extremely rare in paratyphoid fever. The present patient had fever and loose-motions since one month for which he was treated empirically. He subsequently developed oliguria and pleural effusion. Pleural effusion due to Salmonella spp. in immunocompetent children has been rarely reported. A MEDLINE search done on this subject revealed only one report of a case of empyema in an HIV positive, immuno-compromised patient, from which S. paratyphi was recovered(9). However, our patient was otherwise immunocompetent. Another recent report documented a case of pleural empyema due to group B Salmonella in an immunocompetent child with diarrhea(10). An appropriate antibiotic is essential for the treatment of patients with typhoid fever. The recent emergence in developing countries of Salmonella strains with multiresistance has caused major problems. In recent years, ciprofloxacin has emerged as a highly effective agent in the treatment of enteric fever, thus therapeutic failure to quinolones is an important trend of concern(1,11). Recently, nalidixic acid resistant Salmonella strains have also been reported. Thus, all strains of Salmonella must be screened for resistance to nalidixic acid and other quinolones. Subjects infected with nalidixic acid resistant strains require longer courses and prolonged doses of quinolones, or treatment with other antibiotics to which the strains are sensitive(1). The strain in this report was also resistant to nalidixic acid. This is unusual since nalidixic acid resistance in S. paratyphi has rarely been reported. The present regimen for treatment of enteric fever at our hospital comprises of ciprofloxacin or cefixime as first line drugs and ceftriaxone for patients who fail to respond to first line drugs. This patient was successfully treated with ceftriaxone to which the isolate was sensitive. The clinical presentation of enteric fever can be confusing. Our patient had mild icterus. The viral markers for hepatitis viruses were negative, the transaminases were elevated but bilirubin was normal. This may be because the blood chemistry was done after 48 hours of hospitalization. The present report emphasizes the rising incidence of complicated and multiresistant enteric fever in developing countries. Prompt recognition together with specific antimicrobial treatment can result in complete recovery of such patients. With the rapid increase in international travel, clinicians world over should keep enteric fever as one of the differential diagnosis in patients with prolonged and complicated fever. Contributors: PM compiled the data and prepared the manuscript. R was involved with the micro-biologic work-up. LS was the clinician incharge. Funding: None. Competing interests: None stated.
|
References |
|